The Pharmacovigilance folks at the FDA know that fluoroquinolones are damaging mitochondria. Yet, they look the other way. Adding a more severe warning about peripheral neuropathy to the warning label isn’t helpful. People should know that they are increasing their risk of every chronic disease associated with mitochondrial damage and oxidative stress when they take a fluoroquinolone. That would actually be helpful.